![Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin β receptor and the tumor necrosis factor receptor | Clínica e Investigación en Arteriosclerosis Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin β receptor and the tumor necrosis factor receptor | Clínica e Investigación en Arteriosclerosis](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S0214916822000602:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNcxT+B4FjbiPdoCJto3d5S/HQoP7igr9H+17+QiS3QekgRlSEeb/LxKWEiuzoGuIt4tJdEQS72s65Pe8yeqL2ksj/lwJ6MGJ9k9qNcwMHIH7sf7WHWGbwo+/dNeOjuMo/tPBB1H/hOCPEBzb2TPIBqIC2/PIxuAf5P2B28QTMX2+TMZXomr+yReGCN7A/Ymf0wZAhNT7tSkzMkqa4dexe936kkelcn186cVKDMlbMhG9rWLiqHizcZZrprSeLMCwxQTlZdxaiRQ+c58dI3MVhiwxuH2rx2Hc6AjKCWIdS+z1A==)
Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin β receptor and the tumor necrosis factor receptor | Clínica e Investigación en Arteriosclerosis
![Inflammation and tumor progression: signaling pathways and targeted intervention | Signal Transduction and Targeted Therapy Inflammation and tumor progression: signaling pathways and targeted intervention | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-021-00658-5/MediaObjects/41392_2021_658_Fig1_HTML.png)
Inflammation and tumor progression: signaling pathways and targeted intervention | Signal Transduction and Targeted Therapy
![Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin β receptor and the tumor necrosis factor receptor - ScienceDirect Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin β receptor and the tumor necrosis factor receptor - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0214916822000602-gr3.jpg)
Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin β receptor and the tumor necrosis factor receptor - ScienceDirect
![Rol del ligando del factor nuclear kappa Beta (RANKL) en osteoartritis y osteoclastogénesis de equinos fina sangre de carrera. Uso de antiinflamatorios Rol del ligando del factor nuclear kappa Beta (RANKL) en osteoartritis y osteoclastogénesis de equinos fina sangre de carrera. Uso de antiinflamatorios](http://www.scielo.org.pe/img/revistas/rivep/v32n2//1609-9117-rivep-32-02-e20009-gf1.jpg)
Rol del ligando del factor nuclear kappa Beta (RANKL) en osteoartritis y osteoclastogénesis de equinos fina sangre de carrera. Uso de antiinflamatorios
![Unleashing endogenous TNF-alpha as a cancer immunotherapeutic | Journal of Translational Medicine | Full Text Unleashing endogenous TNF-alpha as a cancer immunotherapeutic | Journal of Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12967-018-1611-7/MediaObjects/12967_2018_1611_Fig1_HTML.png)
Unleashing endogenous TNF-alpha as a cancer immunotherapeutic | Journal of Translational Medicine | Full Text
![Frontiers | The Role of Tumor Necrosis Factor in Manipulating the Immunological Response of Tumor Microenvironment Frontiers | The Role of Tumor Necrosis Factor in Manipulating the Immunological Response of Tumor Microenvironment](https://www.frontiersin.org/files/MyHome%20Article%20Library/656908/656908_Thumb_400.jpg)